The Global Market for Ophthalmic Lasers – 2019 to 2024

The global ophthalmic lasers market is expected to register a CAGR of 4.9%, over the forecast period according to Research and Markets.

Factors that are responsible for the growth of this market include high prevalence of ophthalmic disorders, increasing initiatives to control visual impairment, and increasing regulatory approvals for ophthalmic lasers.

FDA is aware that there has been, and continues to be, a considerable amount of research activity in the ophthalmic lasers arena. Hence, several number of eye lasers are receiving regulatory approvals, which help in driving the ophthalmic lasers market.

In 2016, the China Food and Drug Administration (China FDA) had granted regulatory approval for the Ellex Medical Lasers Limited’s complete portfolio of glaucoma, vitreous floaters, and secondary cataract treatment lasers (collectively referred to as the YAG laser portfolio) in the Chinese market.

With the company’s proprietary YAG laser portfolio now available to all ophthalmologists in China, the approval by China FDA had directly increased the sales in China, in 2017. Therefore, it is marked as an important milestone to expand its presence in the fast-growing market of Asia. Thus, the increase in regulatory approvals helps in driving the growth of the ophthalmic lasers market.

Refractive Error Corrections are Expected to Hold the Highest Revenue in the Application Segment

In the application segment of the ophthalmic lasers market, refractive error corrections are projected to have the largest revenue during the forecast period. This is majorly due to the factors, such as the escalating number of refractive error cases among, both, children and adult population. Furthermore, increase in the application of femtosecond lasers in refractive error surgeries is helping in the growth of this segment.

North America Dominates the Market and is Expected to do the Same during the Forecast Period

Currently, North America dominates the market for ophthalmic lasers, and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share, owing to the increasing incidence rates of ophthalmic problems and increasing healthcare expenditure in the country, as well as the development of sophisticated healthcare infrastructure in the country.

Competitive Landscape

The ophthalmic market is moderately competitive and consists of several major players. In terms of the market share, few of the major players currently dominate the market. With rising incidence of ophthalmic cases and increasing geriatric population, few other smaller players are expected to enter the market.

Some of the major players of the market are Alcon Laboratories Inc. (Novartis AG), Johnson & Johnson Surgical Vision Inc., Bausch & Lomb Incorporated (Valeant Pharmaceuticals International Inc.), Ellex Medical Lasers Limited, and IRIDEX Corporation, among others.

Key Topics Covered

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 High Prevalence of Ophthalmic Disorders
4.2.2 Increasing Regulatory Approvals for Ophthalmic Lasers
4.2.3 Increasing Initiatives to Control Visual Impairments
4.3 Market Restraints
4.3.1 Huge Cost Associated with Ophthalmic Laser Therapies
4.3.2 Reduced Availability of Skilled Practitioners
4.4 Porter’s Five Forces Analysis

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Diode Lasers
5.1.2 Femtosecond Lasers
5.1.3 Excimer Lasers
5.1.4 Nd:YAG Lasers
5.1.5 SLT Lasers
5.1.6 Other Products
5.2 By Application
5.2.1 Glaucoma
5.2.2 Cataract Removal
5.2.3 Refractive Error Corrections
5.2.4 Diabetic Retinopathy
5.2.5 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Eye Clinics
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.2 Europe
5.4.3 Asia-Pacific
5.4.4 Middle East & Africa
5.4.5 South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Alcon Laboratories Inc. (Novartis AG)
6.1.2 Johnson & Johnson Surgical Vision Inc.
6.1.3 Bausch & Lomb Incorporated (Valeant Pharmaceuticals International Inc.)
6.1.4 Ellex Medical Lasers Limited
6.1.5 IRIDEX Corporation
6.1.6 LIGHTMED
6.1.7 Quantel Medical
6.1.8 SCHWIND Eye-tech-solutions
6.1.9 Lumenis

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

Santa Casa Hospital System Chooses Carestream for a Unified Diagnostic Workflow

Santa Casa de Misericordia has selected Carestream to replace its legacy diagnostic workflow technology across all seven of its hospitals in Porto Alegre, the capital and largest city of the Brazilian state of Rio Grande do Sul.

American College of Cardiology Thanks Senators McConnell, Kaine for Efforts to Reduce Youth Tobacco...

On behalf of our patients, ACC members thank the Senators for their efforts to reduce youth tobacco use and stand ready to partner with them—and other members of Congress—to enact strong legislation establishing a federal age of 21 for the sale of all tobacco products.”

ResMed Study Finds CPAP Adherence Improved by Remote Monitoring, Self-Monitoring Across 3 Countries

ResMed reports the average adherence to PAP (positive airway pressure), the gold standard for treating sleep apnea, is approximately 50 percent when using legacy technology with no cloud connectivity or remote monitoring capabilities.

Life Image and Bialogics Analytics Partner to Enable Provider Organizations to Optimize Operations, Interoperability

The Life Image and Bialogics partnership will streamline access to analytics of medical imaging in order to help provider organizations enhance operational and financial performance, and improve patient satisfaction.

MediSpin XL™ – Cutting-Edge High-Volume Electrospinning Production Platform for Medical Devices is Launched

The launch of the MediSpin XL™ platform marks a global breakthrough in the controlled large-scale production of well-defined scaffolds for implants and membranes using fibers ranging from nanometer up to micrometer scale.

Hemodialysis Vascular Grafts Market Size Worth $276.5 Million By 2025

Increasing number of patients suffering from chronic kidney diseases (CKD) and growing adoption of biological access products due to technological advancements in the field are some of the factors contributing to revenue growth. Higher number of renal impaired patients and limited availability of suitable kidney donors are promoting hemodialysis procedures in renal impaired patients, which in turn is expected to fuel the demand for vascular grafts over the forecast period.